XML 56 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Measurements  
Summary of significant inputs as of the valuation dates

September 30, 

January 7

2025

2025

Series A

Series B

Series A

Series B

(Level 3)

(Level 3)

(Level 3)

(Level 3)

Stock Price

$

0.81

$

0.81

$

15.91

$

15.91

Exercise Price

8.06

8.06

45.00

45.00

Expected volatility

 

151.00%

203.00%

 

99.00%

130.00%

Risk-free interest rate

 

3.70%

3.60%

 

4.36%

4.22%

Expected life (in years)

 

4.27

1.77

 

5.00

2.50

Expected dividend yield

 

 

Summary of recurring measurements for assets and liabilities at fair value

The following details the Company’s recurring measurements for assets and liabilities at fair value (in thousands):

Convertible Notes

Warrant Liabilities

Contingent Consideration

Embedded Forward Purchase Agreement and Make Whole Derivative

(Level 3)

(Level 3)

(Level 3)

(Level 3)

Balance, January 1, 2025

$

11,689

$

1,187

$

3,541

$

Issuance of convertible notes

Issuance of warrants

93,986

Change in fair value

5,362

(85,950)

(3,509)

Warrant cashless exercise

(6,885)

Termination of forward purchase agreements

Balance, September 30, 2025

$

17,051

$

2,338

$

32

$

Balance, January 1, 2024

$

$

1,447

$

104,350

$

41,043

Issuance of convertible notes

15,000

Change in fair value

170

15,376

(97,464)

(399)

Warrant cashless exercise

(14,979)

Termination of forward purchase agreements

(40,380)

Balance, September 30, 2024

$

15,170

$

1,844

$

6,886

$

264

Public and private warrants  
Fair Value Measurements  
Summary of the Company's issued and outstanding public warrants

Public

Private

Issued and Outstanding, January 1, 2025

55,403

Number of warrants issued

Number of warrants exercised

Number of warrants cancelled

Issued and Outstanding, September 30, 2025

55,403

Issued and Outstanding, January 1, 2024

127,778

73,334

Number of warrants exercised

(124,897)

(17,931)

Number of warrants cancelled

(2,881)

Issued and Outstanding, September 30, 2024

55,403

Series A and B warrants  
Fair Value Measurements  
Summary of activity for the Company's issued and outstanding warrants

Series A

Series B

Issued and Outstanding, January 1, 2025

Number of warrants issued

3,565,245

3,565,245

Number of warrants exercised

(3,438,095)

Issued and Outstanding, September 30, 2025

3,565,245

127,150